Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2013

Mar 4, 2013

29821_dirs_2013-03-04_1c4cc2c3-915c-4692-80bb-dd47770c2d04.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-02-28

Reporting Person: Bose Supratim (EVP & President, Asia-Pacific)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-28 Deferred Stock Units $ A 33829.0000 Acquired 2018-02-28 Common Stock (33829.0000) Direct
2013-02-28 Performance Share Units $ A 20701.0000 Acquired 2014-12-31 Common Stock (20701.0000) Direct
2013-02-28 Stock Option (Right to Buy) $7.3900 A 88071.0000 Acquired 2023-02-28 Common Stock (88071.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.

F3: Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4: On February 27, 2012, the reporting person was awarded a target number of performance share units under the Company's 2012 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2012 adjusted free cash flow measured against its 2012 financial plan over the one-year performance period ending December 31, 2012 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2013, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2014 upon the completion of the individual service period.

F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.